BR112014015358A8 - composição de extratos enriquecidos com elagitaninos - Google Patents

composição de extratos enriquecidos com elagitaninos

Info

Publication number
BR112014015358A8
BR112014015358A8 BR112014015358A BR112014015358A BR112014015358A8 BR 112014015358 A8 BR112014015358 A8 BR 112014015358A8 BR 112014015358 A BR112014015358 A BR 112014015358A BR 112014015358 A BR112014015358 A BR 112014015358A BR 112014015358 A8 BR112014015358 A8 BR 112014015358A8
Authority
BR
Brazil
Prior art keywords
elagitanine
composition
extracts
enriched extracts
enriched
Prior art date
Application number
BR112014015358A
Other languages
English (en)
Other versions
BR112014015358A2 (pt
Inventor
Burki Carolina
Schoenlau Frank
Ferrari Victor
Original Assignee
Horphag Res Ip Qr Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Horphag Res Ip Qr Ltd filed Critical Horphag Res Ip Qr Ltd
Publication of BR112014015358A8 publication Critical patent/BR112014015358A8/pt
Publication of BR112014015358A2 publication Critical patent/BR112014015358A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

resumo composição de extratos enriquecidos com elagitaninos. a presente invenção refere-se a uma composição que consiste em extratos ricos em elagitaninos a partir de extratos de plantas da família fagaceae, para utilização em um método para prevenir ou tratar a fadiga, transtornos do sono, ansiedade, melhora do humor e aumento da energia de um indivíduo.
BR112014015358A 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos BR112014015358A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH20452011 2011-12-23
PCT/EP2012/076845 WO2013093102A1 (en) 2011-12-23 2012-12-21 Ellagitannins rich extracts composition

Publications (2)

Publication Number Publication Date
BR112014015358A8 true BR112014015358A8 (pt) 2017-06-13
BR112014015358A2 BR112014015358A2 (pt) 2017-06-13

Family

ID=47557106

Family Applications (2)

Application Number Title Priority Date Filing Date
BR112014015354A BR112014015354A2 (pt) 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos no bem-estar sexual
BR112014015358A BR112014015358A2 (pt) 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BR112014015354A BR112014015354A2 (pt) 2011-12-23 2012-12-21 composição de extratos enriquecidos com elagitaninos no bem-estar sexual

Country Status (15)

Country Link
US (2) US9066924B2 (pt)
EP (2) EP2793905B1 (pt)
JP (2) JP2015502170A (pt)
CN (2) CN104271141B (pt)
BR (2) BR112014015354A2 (pt)
CA (2) CA2859062C (pt)
DK (2) DK2800572T3 (pt)
HR (1) HRP20160758T1 (pt)
PL (1) PL2793905T3 (pt)
PT (1) PT2793905E (pt)
SG (4) SG11201403425WA (pt)
SI (1) SI2793905T1 (pt)
TW (1) TWI583390B (pt)
WO (2) WO2013093096A1 (pt)
ZA (2) ZA201403827B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10238684B2 (en) * 2010-11-18 2019-03-26 Foundational Biosystems, Llc Micro- and nano-quantity sleep enhancing nutrient composition and method of enhancing central nervous system protein clearance using same
FR3055215B1 (fr) * 2016-08-31 2020-02-14 S.A.M. Serelys Pharma Composition comprenant des extraits de pollen et /ou de pistils
CN108041588A (zh) * 2017-12-08 2018-05-18 冯纪敏 一种含有海藻糖的组合物及其应用
WO2019213464A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal atrophy
WO2019213473A1 (en) * 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
JP7185260B2 (ja) * 2018-06-18 2022-12-07 株式会社Active 悪夢障害の治療用医薬組成物
WO2020006191A1 (en) * 2018-06-29 2020-01-02 The Procter & Gamble Company Vaginal care compositions
CN109287852B (zh) * 2018-09-18 2021-12-28 青岛农业大学 一种利用板栗花水提取物提高动物精液品质的方法
WO2020096992A1 (en) * 2018-11-05 2020-05-14 MarvelBiome, Inc. Microbial compositions comprising ellagitannin and methods of use
IT202000004747A1 (it) * 2020-03-06 2021-09-06 A M Italy S R L Composizione per l’uso nella terapia, in particolare per la cura dell’ansia
FI20215341A1 (fi) 2021-03-25 2022-09-26 Finthinktur Oy Liuottimen avulla valmistettu uute ja menetelmä uutteen valmistamiseksi

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000136145A (ja) * 1998-10-29 2000-05-16 Nikka Whisky Distilling Co Ltd 樽材抽出物
US8372454B2 (en) * 1999-04-19 2013-02-12 Pom Wonderful Llc Methods of making pomegranate compounds for the treatment of erectile dysfunction
US20040247698A1 (en) * 2003-06-04 2004-12-09 Valenzuela Cortes Carmen Maria Erectile Dysfunction Treatment
CN100566723C (zh) * 2004-09-13 2009-12-09 辻田隆广 衍生自壳斗植物的糖酶抑制剂及其应用
JP2006104067A (ja) * 2004-09-30 2006-04-20 Suntory Ltd 自律神経機能を調節する作用を有する香気組成物、およびその利用
JP4778813B2 (ja) * 2006-03-07 2011-09-21 株式会社ロッテ メチオニナーゼ阻害剤
WO2009114810A2 (en) * 2008-03-14 2009-09-17 The Florida International Uinversity Board Of Trustees Use of ellagitannins as inhibitors of bacterial quorum sensing
US9028890B2 (en) * 2010-06-25 2015-05-12 Horphag Research (Ip) Pre Ltd. Composition for improving sexual wellness

Also Published As

Publication number Publication date
PT2793905E (pt) 2016-06-20
CA2859062A1 (en) 2013-06-27
ZA201403827B (en) 2015-10-28
CN104053444A (zh) 2014-09-17
HRP20160758T1 (hr) 2016-08-12
US20140322369A1 (en) 2014-10-30
CN104053444B (zh) 2017-11-07
BR112014015354A8 (pt) 2017-06-13
DK2793905T3 (en) 2016-08-01
EP2800572A1 (en) 2014-11-12
JP2015502170A (ja) 2015-01-22
WO2013093096A8 (en) 2014-11-27
SG11201403431WA (en) 2014-11-27
DK2800572T3 (da) 2017-11-20
TWI583390B (zh) 2017-05-21
BR112014015354A2 (pt) 2017-06-13
JP5918389B2 (ja) 2016-05-18
SG11201403425WA (en) 2014-10-30
CN104271141A (zh) 2015-01-07
PL2793905T3 (pl) 2016-10-31
EP2793905A1 (en) 2014-10-29
WO2013093096A1 (en) 2013-06-27
EP2800572B1 (en) 2017-08-16
US20140343134A1 (en) 2014-11-20
SI2793905T1 (sl) 2016-08-31
SG10201602856YA (en) 2016-05-30
TW201340976A (zh) 2013-10-16
CA2859066A1 (en) 2013-06-27
EP2793905B1 (en) 2016-04-06
CA2859062C (en) 2019-10-29
CA2859066C (en) 2020-07-14
BR112014015358A2 (pt) 2017-06-13
CN104271141B (zh) 2017-08-18
WO2013093102A1 (en) 2013-06-27
SG10201602847XA (en) 2016-05-30
JP2015511212A (ja) 2015-04-16
US9060999B2 (en) 2015-06-23
ZA201404005B (en) 2017-08-30
US9066924B2 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
BR112014015358A8 (pt) composição de extratos enriquecidos com elagitaninos
BR112016010422A8 (pt) suplemento dietético, e uso de uma composição
BR112012022755A2 (pt) composição com bactérias probióticas para uso no tratamento de distúrbios imunológicos
BR112014030282A2 (pt) métodos de tratamento de excesso de peso e obesidade
BR112014012050A2 (pt) método para produção de uma escova de dentes que tem uma cavidade interna
BR112015022472A2 (pt) método e sistema para prever a resposta a tratamentos para transtornos mentais
CU20130137A7 (es) Derivados de ácido 3- fenilpropiónico ramificados y su uso
BR112013000537A2 (pt) composição aquosa contendo bromexina
BR112013032229A2 (pt) método de tratamento hidrocatalítico hidrotérmico de biomassa, e, composição
BR112016012870A8 (pt) composições e métodos para melhorar a produção de alface
CU20140025A7 (es) Pirimidinas anilladas sustituidas
UY32456A (es) Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento
BR112012029551A2 (pt) processo para preparação de microcápsulas de poliureia
BR112013018836A2 (pt) "métodos de manipulação, obtenção, elevação e aumento em uma planta que compreende a expressão de gene modificado"
CL2013002210A1 (es) Formulación prebiótica para consumo humano que comprende 2´-fucosilactosa, 3´-sialilactosa y 6´-sialilactosa, en que la cantidad en peso de 3´-sialilactosa es al menos igual de elevada que la cantidad de 2´-fucosilactosa; y método para modular o estimular la proliferación de bifidobacterias en el intestino humano.
GT201400101A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
GB2503852A (en) Compounds for the treatment of neuropsychiatric disorders
BR112015023031A2 (pt) métodos de conservação e melhoria da função múscular
BR112014006587A8 (pt) Composto compreendendo oligonucleotídeo que modula a expressão de gcgr, composição, bem como seu uso no tratamento ou prevenção de diabetes
WO2012125408A8 (en) Pegylated apelin and uses thereof
BR112015005653A2 (pt) Método de promover o desenvolvimento de oócitos maduros e de aumentar a polimerização de actina em tecido ovariano, e uso de um agente que perturba a sinalização na trajetória hippo, ou um agente que age a jusante da sinalização hippo perturbada
BR112012030764A2 (pt) métodos para tratamento de distúrbios metotrexato-resistentes com 10-propargil-10-deazaanibopterin
BR112014000634A2 (pt) métodos para tratamento de incontinência associada com atividade sexual
MX2012014163A (es) Uso de acido sialico, precursor de acido sialico o una combinacion de los anteriores para preparar medicamentos utiles en una condicion diabetica o sindrome nefrotico.
BR112012019920A2 (pt) derivados de piridazina úteis como agonístas de canabinoide-2.

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL